Evaluation of a side population of canine lymphoma cells using Hoechst 33342 dye

Journal of Veterinary Science

Volumn 14, Issue 4, 2013, Pages 481-486

  Kim, Myung Chul ^a   D'Costa, Susan ^b   Suter, Steven ^b   Kim, Yongbaek ^a  

^a Seoul National University   (South Korea)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Dog; Flow cytometry; Hoechst 33342; Lymphoma; Side population

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; FLUORESCENT DYE; HOE 33342;

ANIMAL; ANIMAL DISEASE; ARTICLE; CANCER STEM CELL; DOG; DOG DISEASE; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; LYMPHOMA; METABOLISM; METHODOLOGY; PATHOLOGY; SIDE POPULATION; SIDE POPULATION CELL; TUMOR CELL LINE;

DOG; FLOW CYTOMETRY; HOECHST 33342; LYMPHOMA; SIDE POPULATION;

ANIMALS; BENZIMIDAZOLES; CELL LINE, TUMOR; DOG DISEASES; DOGS; FLOW CYTOMETRY; FLUORESCENT DYES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LYMPHOMA; NEOPLASTIC STEM CELLS; SIDE-POPULATION CELLS;

EID: 84893465757     PISSN: 1229845X     EISSN: 1976555X     Source Type: Journal    
DOI: 10.4142/jvs.2013.14.4.481     Document Type: Article

References (22)

1. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996, 183, 1797-1806.
2. Greenlee PG, Filippa DA, Quimby FW, Patnaik AK, Calvano SE, Matus RE, Kimmel M, Hurvitz AI, Lieberman PH. Lymphomas in dogs: a morphologic, immunologic, and clinical study. Cancer 1990, 66, 480-490.
3. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, Mori M. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006, 24, 506-513.
4. Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ, Chen IM, Atlas SR, Kang H, Ar K, Wilson CS, Wharton W, Murphy M, Devidas M, Carroll AJ, Borowitz MJ, Bowman WP, Downing JR, Relling M, Yang J, Bhojwani D, Carroll WL, Camitta B, Reaman GH, Smith M, Hunger SP, Willman CL. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 2010, 116, 4874-4884.
5. Kai K, D'Costa S, Yoon BI, Brody AR, Sills RC, Kim Y. Characterization of side population cells in human malignant mesothelioma cell lines. Lung Cancer 2010, 70, 146-151.
6. Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 2002, 8, 22-28.
7. Kiupel M, Teske E, Bostock D. Prognostic factors for treated canine malignant lymphoma. Vet Pathol 1999, 36, 292-300.
8. Levine RL. Inherited susceptibility to pediatric acute lymphoblastic leukemia. Nat Genet 2009, 41, 957-958.
9. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007, 23, 675-699.
10. Lohberger B, Rinner B, Stuendl N, Absenger M, Liegl-Atzwanger B, Walzer SM, Windhager R, Leithner A. Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma. PLoS One 2012, 7, e43664.
11. MacEwen EG. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 1990, 9, 125-136.
12. MacEwen EG, Hayes AA, Matus RE, Kurzman I. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981). J Am Vet Med Assoc 1987, 190, 564-568.
13. Montanaro F, Liadaki K, Schienda J, Flint A, Gussoni E, Kunkel LM. Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp Cell Res 2004, 298, 144-154.
14. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006, 107, 265-276.
15. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 2005, 65, 6207-6219.
16. Ponce F, Magnol JP, Ledieu D, Marchal T, Turinelli V, Chalvet-Monfray K, Fournel-Fleury C. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Vet J 2004, 167, 158-166.
17. Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 2000, 60, 47-50.
18. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414, 105-111.
19. Suzuyama N, Katoh M, Takeuchi T, Yoshitomi S, Higuchi T, Asashi S, Yokoi T. Species differences of inhibitory effects on P-glycoprotein-mediated drug transport. J Pharm Sci 2007, 96, 1609-1618.
20. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci U S A 2006, 103, 11154-11159.
21. Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, La Noce M, Laino L, De Francesco F, Papaccio G. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J 2013, 27, 13-24.
22. Vail DM, MacEwen EG. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 2000, 18, 781-792.